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DOI 10.1186/s12904-017-0194-zRESEARCH ARTICLE Open AccessIs admittance to specialised palliative care
among cancer patients related to sex, age
and cancer diagnosis? A nation-wide study
from the Danish Palliative Care Database
(DPD)
Mathilde Adsersen1* , Lau Caspar Thygesen2, Anders Bonde Jensen3, Mette Asbjoern Neergaard4, Per Sjøgren5
and Mogens Groenvold1,6Abstract
Background: Specialised palliative care (SPC) takes place in specialised services for patients with complex symptoms and
problems. Little is known about what determines the admission of patients to SPC and whether there are differences in
relation to institution type. The aims of the study were to investigate whether cancer patients’ admittance to SPC in
Denmark varied in relation to sex, age and diagnosis, and whether the patterns differed by type of institution
(hospital-based palliative care team/unit, hospice, or both).
Methods: This was a register-based study of adult patients living in Denmark who died from cancer in 2010–2012. Data
sources were the Danish Palliative Care Database, Danish Register of Causes of Death and Danish Cancer Registry. The
associations between the explanatory variables (sex, age, diagnosis) and admittance to SPC were investigated using
logistic regression.
Results: In the study population (N = 44,548) the overall admittance proportion to SPC was 37%. Higher odds of overall
admittance to SPC were found for women (OR = 1.23; 1.17–1.28), younger patients (<40 compared with 80+ years old)
(OR = 6.44; 5.19–7.99) and patients with sarcoma, pancreatic and stomach cancers, whereas the lowest were for patients
with haematological malignancies. The higher admission found for women was most pronounced for hospices
compared to hospital-based palliative care teams/units, whereas higher admission of younger patients was
more pronounced for hospital-based palliative care teams/units. Patients with brain cancer were more often
admitted to hospices, whereas patients with prostate cancer were more often admitted to hospital-based
palliative care teams/units.
Conclusion: It is unlikely that the variations in relation to sex, age and cancer diagnoses can be fully explained
by differences in need. Future research should investigate whether the groups having the lowest admittance to
SPC receive sufficient palliative care elsewhere.
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Specialised palliative care (SPC) takes place in specia-
lised services for patients with complex symptoms and
problems [1] and the majority of patients admitted to
SPC worldwide and in Denmark have cancer diagnoses
(about 95% in Denmark) [2, 3]. In Denmark SPC takes
place in hospital-based palliative care teams/units and
in hospices, but there are no national guidelines for
referral of patients to SPC. Little is known about what
determines the admission of patients to SPC [4] and
whether there are differences in relation to institution
type (hospital-based palliative care teams/units versus
hospices).
Differences in symptoms and problems could ex-
plain differences in admittance to SPC. In a Danish
nationally representative sample of patients with
advanced cancer, it was shown that the majority of symp-
toms and problems were not associated with sex. The only
differences reported were that patients with lung can-
cer had more symptoms and problems than patients
with other cancer diagnoses and that older patients
had more symptoms and problems compared with
younger patients [5, 6].
In an optimally functioning health care system, admit-
tance to SPC would be directly related to the level of needs.
Other explanations could be differences in awareness, tradi-
tions and attitudes among the referring departments and
SPC units. For example, there could be differences in the
capacity among hospital departments and thereby in the in-
centive to refer patients to SPC. If such factors determine
the referral, it may result in inequality (i.e., that patients
with the same needs have different likelihood of admission)
in admittance to SPC.
From the results of the previously mentioned Danish
study of symptoms and problems among patients with
advanced cancer, we have no reason to believe that
certain subgroups defined by sex, age or cancer diag-
nosis will have higher needs for SPC; exceptions may
be older persons and patients with lung cancer since
these two groups had more symptoms [5, 6].
The aims of the present study were to investigate
whether overall admittance to SPC in Denmark for
adults who died from cancer varied with sex, age and
cancer diagnosis, and whether the (admittance) pat-
terns were different according to type of institution
(admission to hospital-based palliative care teams/
units, hospices, or both types of institutions).Methods
This is a Danish nation-wide register-based study. The
unique Danish personal identification number (CPR-
number) makes it possible to collect and merge data
from different registers.Setting
There are two types of SPC institutions in Denmark
(5.7 million inhabitants) but the characteristics of these
are not mutually exclusive. First, there are hospices,
and some of these also have a home care team (four
out of 18 hospices had a home care team in addition to
their in-patient facility). Hospices are free-standing
services, separate from the rest of the health care sys-
tem, and are publicly financed with no payment from
patients. Secondly, there are hospital-based palliative
care teams/units with or without an in-patient unit (five
out of 26 hospital-based palliative care teams/units
have an in-patient unit in addition to their home care
and out-patient services). The teams/units are placed at
hospitals, and are also fully publicly financed. During
the study period, the number of SPC units in Denmark
increased from 36 to 44 units [2].
About 80% of the patients admitted to SPC had contact
with only one SPC unit (either a hospice or a hospital-
based palliative care team/unit), whereas about 20% of the
patients had contact with two or more SPC units, typically
a hospital-based palliative care team followed by a hospice.
All of these SPC units are expected to have multidisciplin-
ary teams and to have weekly multidisciplinary meetings
about their patients. The median survival time from the
first referral to SPC to death was 27 days (mean 55 days)
for patients admitted to a hospice, and for those admitted
to a hospital-based palliative care team/unit it was 50 days
(mean 90 days) [7].
Data sources and variables
Danish Palliative Care Database (DPD) is a national quality
of care database, and since 1 January 2010, it has been
mandatory for all SPC units in Denmark to register all re-
ferred patients in the DPD. The DPD data about admission
is validated against the Danish National Patient Register [8]
in close collaboration with the SPC units. DPD has a high
patient completeness, which has increased from 95.7% in
2010 [9] to 100% in 2012 [2]. Information about sex, age at
the time of death, admittance to SPC (hospital-based
palliative care team/unit and/or hospice) was collected
from DPD.
Deaths among individuals living in Denmark are
registered in Danish Register of Causes of Death (RCD).
Information on cause of death is reported by the physician
certifying the death. More than 99% of the death certifi-
cates contain complete data [10]. Data about the under-
lying cause of death (diagnosis) and date of death were
obtained from RCD.
The Danish Cancer Registry (CR) is a population-based
research register and contains incident cancer diagnoses
since 1943. From 1987 it has been mandatory to report to
CR [11]. CR contributed with information about cancer
diagnoses.
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Overall admittance: a dichotomous (yes/no) variable
defined as any personal contact with SPC (inpatient,
home visit, outpatient or palliative care team visits to
inpatients at non-SPC departments). For patients with
more than one contact the information from the first
contact was included.
Institution type specific admittance: Overall admittance
subdivided after type, i.e., hospital-based palliative care
team/unit, hospice or both.
Explanatory variables: sex, age at the time of death
grouped as: 18–39, 40–49, 50–59, 60–69, 70–79, 80+
years, and cancer diagnosis coded using ICD-10
(Table 1).
Population/sample
From RCD we identified adults (at least 18 years old)
with cancer as the underlying cause of death in 2010–
2012 including all ICD-10 C-codes and the D-codes for
cancers in the brain (see Table 1). The death causes of
cancer were validated against the CR [11]: (i) For most
patients (84%) the same diagnosis was found in the two
registers. (ii) Different diagnoses were found for 12%,
these individuals were included in the study with the
cancer diagnosis registered in CR. If there was more
than one cancer registration, the latest was used. (iii)
Patients with no cancer diagnosis registered in the CR
were excluded (4%, N = 1,773). After these exclusions
44,548 patients were included in the study (Fig. 1).
Data analysis
The associations between the explanatory variables (sex,
age and cancer diagnosis) and overall admittance to SPC
were investigated using unadjusted and adjusted logistic
regression analysis including all the explanatory variables
in the model. In addition, three separate multiple logistic
regression analyses were made for admittance to hospital-
based palliative care team/unit, hospice or both, respect-
ively, adjusted for sex, age and diagnosis. The reference
group for diagnosis was the average of admittance for all
diagnoses. The results from the logistic regressions are
reported as odds ratios (ORs) with 95% confidence inter-
vals (CIs). As level of statistical significance p < 0.05 was
used. The analyses were carried out using SAS statistical
software version 9.3 [12].
Results
In the study population (N = 44,548), the overall admittance
proportion to SPC was 37.4% of all patients dying of cancer
in 2010–12. The institution type specific admittance
was 26.8% for hospital-based palliative care team/unit
and 17.3% for hospice. Thus, some patients (6.8%) wereadmitted to hospital-based palliative care team/unit and
hospice (Table 1).
Sex
In the study population slightly more than half were
men (52.3%). Overall, women had a higher admittance
proportion (39.5%) than men (35.5%) (Table 1).
The multiple logistic regression analysis showed that
overall, women were more likely to be admitted to SPC
than men (OR= 1.23; 95% CI:1.17–1.28) (Table 2). The in-
stitution type specific admittance analyses showed that this
sex difference was more pronounced in relation to hospice
(OR = 1.45; 95% CI:1.37–1.54), than for hospital-based
palliative care team/unit (OR = 1.06; 95% CI:1.00–1.11).
Age
Most patients were above the age of 60 years (85%),
while only 0.9% were 18–39 years old (Table 1). A much
higher admittance proportion to SPC was found for younger
compared with older patients; the overall admittance
proportion decreased from 65.0% for individuals 18–39
years of age to 24.3% for those age 80+ years old (Table 1).
In the multiple logistic regression analysis a strong
association between age and overall admittance was found
(Table 2). The odds of admittance to SPC were over six
times higher for the youngest (18–39 years old) compared
to the 80+ years old (OR = 6.44; 95% CI:5.19–7.99). Look-
ing at institution type specific admittance, the differences
between age groups were more pronounced for admit-
tance to hospital-based palliative care team/unit than for
hospice.
Diagnosis
The most common cancer diagnoses in the study popu-
lation were lung (23.2%), colorectal (12.7%) and breast
cancer (8.1%) (Table 1).
The highest odds of overall admittance to SPC were found
for individuals with sarcoma (OR= 1.90; 95% CI:1.52–2.38),
pancreatic (OR = 1.77; 95% CI:1.61–1.94) and stomach
cancer (OR = 1.69; 95% CI:1.50–1.90) compared with
the average of all diagnoses (Table 2). The lowest odds
of overall admittance to SPC were found for patients with
haematological malignancies with odds ratios between 0.33
(95% CI:0.17–0.63) and 0.50 (95% CI:0.42–0.61).
The multiple logistic regression analyses of the institution
type specific admittance showed a somewhat different
pattern in relation to diagnosis. The admittance to
hospital-based palliative care team/unit was consistent
with the overall admittance to SPC. High admittance to
hospice was also found in relation to patients with sarcoma
cancer (OR = 1.54; 95% CI:1.20–1.98), but the highest odds
were for patients with ovarian cancer (OR = 1.56; 95%
CI:1.35–1.80). Again the lowest odds of admittance
were found for patients with haematological malignancies
Table 1 The characteristics of the study population overall and institution type specific admittance
N Overall admittance
to SPC
Admittance to
hospital-based
palliative care
team/unit
Admittance
to Hospice
Admittance to both
hospital-based palliative
care team/unit and
hospice
(%) % % % %
All cancer diagnoses 44,548 (100) 37.4 26.8 17.3 6.8
Sex
Men 23,312 (52.3) 35.5 26.8 14.7 6.0
Women 21,236 (47.7) 39.5 26.8 20.2 7.8
Age (years)
18–39 406 (0.9) 65.0 52.2 30.5 17.7
40–49 1,353 (3.0) 59.7 46.3 29.3 16.0
50–59 4,521 (10.2) 51.1 39.2 22.8 10.8
60–69 11,221 (25.2) 44.3 32.5 20.3 8.5
70–79 13,870 (31.1) 36.7 25.9 16.9 6.1
80+ 13,177 (29.6) 24.3 15.9 11.7 3.3
Diagnosis (cancer site)
Oral cavity, nasopharyngeal (etc.) (C00-C14) 998 (2.2) 37.7 30.0 16.2 8.5
Oesophageal (C15) 1,101 (2.5) 43.0 32.5 17.3 6.8
Stomach (C16) 1,285 (2.9) 47.6 35.4 22.0 9.9
Small intestine (C17) 162 (0.4) 40.1 30.9 17.3 8.0
Colorectal (C18–C20) 5,649 (12.7) 36.0 25.9 16.7 6.6
Liver (etc.) (C22) 845 (1.9) 34.7 24.6 14.0 3.9
Pancreatic (C25) 2,473 (5.6) 49.4 34.9 22.6 8.1
Laryngeal (C32) 280 (0.6) 29.6 22.5 12.9 5.7
Tracheal, bronchial and lung (C33–C34) 10,338 (23.2) 39.5 28.2 18.4 7.1
Melanoma skin cancer (C43) 774 (1.7) 45.1 31.7 23.1 9.7
Sarcoma (C46–C49) 326 (0.7) 54.9 40.8 25.8 11.7
Breast (C50) 3,618 (8.1) 37.3 25.9 18.3 6.9
Cervical (C53) 301 (0.7) 45.2 31.6 26.3 12.6
Uterine (C54–55) 499 (1.1) 42.1 29.1 20.2 7.2
Ovarian (etc.) (C56,C570–C574) 1,109 (2.5) 49.9 33.3 27.7 11.1
Prostate (C61) 3,512 (7.9) 33.9 27.7 12.6 6.4
Testicular (C62) 39 (0.1) 30.8 28.2 12.8 10.3
Kidney (etc.) (C64–C66) 991 (2.2) 44.4 33.5 18.8 7.9
Bladder (C67) 1,378 (3.1) 32.3 24.2 13.4 5.4
Brain/central nervous system (C70–C71, C751–C753)a 1,407 (3.2) 40.9 26.0 22.3 7.4
Thyroid (C73) 114 (0.3) 45.6 32.5 21.1 7.9
Unknown primary cancer (C76–C80) 1,802 (4.1) 32.4 21.6 15.8 5.1
Hodgkin disease (C81) 58 (0.1) 19.0 13.8 10.3 5.2
Non-Hodgkin lymphoma (C82-C85) 814 (1.8) 20.2 11.7 11.4 3.0
Multiple myeloma (C 90) 635 (1.4) 20.6 14.0 9.3 2.7
Leukemia (C91–C95) 1,200 (2.7) 15.3 8.4 7.9 1.1
Other cancer (all other C codes) 2,840 (6.4) 29.9 21.4 13.8 5.3
aIncluding the following D-codes: D32, D42, D330–332, D352–354, D430–432, D443–445, D333–339 and D433–439
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Fig. 1 Flow-chart for sampling the study population
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some cancer diagnoses large differences were seen
between use of hospital-based palliative care team/unit
and hospice: for patients with brain cancer the odds of
admittance to hospice were markedly above the average of
all diagnoses, whereas the odds of admittance to hospital-
based palliative care teams/units were below the average
of all diagnoses. In relation to patients with prostate
cancer the reverse pattern was found.
Discussion
We found relatively large differences in admittance to
SPC: lower admittance to SPC for men (most pronounced
for hospice than hospital-based palliative care team/unit),
markedly lower admission for older patients (more pro-
nounced for hospital-based palliative care team/unit than
hospice) and lower admission for patients with haemato-
logical diseases. For two cancer diagnoses the patterns
were opposite: there was higher admittance than average
to hospice and lower admittance to hospital-based pallia-
tive care team/unit for patients with brain cancer whereas
there was higher admittance to hospital-based palliative
care team/unit and lower to hospice for patients with
prostate cancer.
The study was based on data from well-established
nation-wide registers with high completeness [2, 7, 9, 11, 13].
This ensured a large national study population (N= 44,548)
of all patients who died of cancer in 2010–2012 in Denmark,
which makes it possible to study the population in detail, e.g.
looking at the different diagnoses separately. Further, it en-
sures representativeness and minimizes the effect of selection
bias [14]. We have found no other studies of similar size andquality, and no previous studies have been comparing
the patterns of admittance to different types of SPC
institutions.
A high validity of the variable “admittance to SPC”
from the DPD was ensured by validating the data of
admittance from DPD against the Danish National
Patient Register [8] and SPC institutions were con-
tacted if uncertainties were present the. Furthermore,
the cancer diagnoses registered in the Danish Register
of Causes of Death were validated against the Danish
Cancer Registry, which has high quality of data with
89% of the tumours being morphologically verified
[11]. In the present study only 1,773 (4%) patients
were excluded because the registration of the cancer
diagnoses in the Danish Register of Causes of Death
was not found in the Danish Cancer Registry. This en-
sured high validity of the diagnosis variable and with
the very limited number of cases excluded one must
expect only a minor influence on the results.
The results from the present study can be compared
with the results from a large Danish study, described in
the introduction, investigating symptoms and problems
in patients with advanced cancer [5, 6].
We found that women were more often admitted to
SPC, especially to hospice (OR 1.45; 1.37–1.54). The
Danish study of needs [5, 6] showed only minor differences
in symptoms and problems in relation to sex, although
there was a tendency towards worse emotional function for
women with solid tumours [5, 6]. Such a difference might
contribute to the sex difference but it seems unlikely that it
explains the marked disparity found in this study. Some
earlier studies reported higher admittance to SPC for
women [15–18], whereas most studies did not show any
differences [3]. The sex difference found in Denmark could
be explained by traditional sex roles where women to a
larger extent than men provide end of life care at home
to their partner. Other possible explanations could be
that the needs of women are more compatible with
hospice or that more women prefer the hospice option.
It might also be that women are better at recognizing
and articulating a need for hospice; this would be in
line with findings that women are more likely to talk
about their own impending death [19] and to acknow-
ledge that their illness is incurable [20].
In the present study admittance to SPC decreased with
increasing age, whereas the study of symptoms and
problems found that symptoms and problems seemed
to increase with increasing age [5, 6]. Our results are in
line with earlier studies [21] although the age gradient
was much stronger in our study [16, 22–25]. Comparing
the youngest with the oldest patients a stronger associ-
ation was found for hospital-based palliative care team/
unit (OR = 6.81; 5.53–8.38) than for hospice (OR = 3.17;
2.57–3.97). With the limited SPC capacity and if we
Table 2 Overall and institution type specific odds of admittance to SPC for Danish cancer patients, mutually adjusted
Overall admittance
to SPC
Admittance to hospital-based
palliative care team/unit
Admittance to
hospice
Admittance to both
hospital-based palliative
care team/unit and hospice
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Sex (P < 0.001) (P < 0.033) (P < 0.001) (P < 0.001)
Women 1.23 (1.17–1.28) 1.06 (1.00–1.11) 1.45 (1.37–1.54) 1.34 (1.23–1.47)
Men 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Age (years) (P < 0.001) (P < 0.001) (P < 0.001) (P < 0.001)
18–39 6.44 (5.19–7.99) 6.81 (5.53–8.38) 3.17 (2.54–3.97) 6.73 (5.08–8.93)
40–49 4.60 (4.09–5.18) 4.80 (4.26–5.41) 2.90 (2.54–3.31) 5.64 (4.72–6.74)
50–59 3.22 (3.00–3.47) 3.48 (3.22–3.76) 2.13 (1.94–2.32) 3.63 (3.16–4.17)
60–69 2.46 (2.32–2.60) 2.56 (2.41–2.73) 1.89 (1.76–2.03) 2.80 (2.49–3.16)
70–79 1.80 (1.70–1.89) 1.86 (1.75–1.97) 1.52 (1.42–1.64) 1.97 (1.74–2.22)
80+ 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Diagnosis (cancer site) (P < 0.001) (P < 0.001) (P < 0.001) (P < 0.001)
Oral cavity, nasopharyngeal (etc.)
(C00–C14)
0.95 (0.83–1.09) 1.07 (0.93–1.23) 0.94 (0.79–1.12) 1.23 (0.97–1.55)
Oesophageal (C15) 1.34 (1.18–1.52) 1.36 (1.19–1.56) 1.09 (0.93–1.29) 1.08 (0.85–1.38)
Stomach (C16) 1.69 (1.50–1.90) 1.63 (1.44–1.85) 1.50 (1.30–1.73) 1.67 (1.37–2.04)
Small intestine (C17) 1.23 (0.89–1.68) 1.34 (0.96–1.87) 1.07 (0.72–1.59) 1.31 (0.75–2.29)
Colorectal (C18–C20) 1.13 (1.05–1.22) 1.16 (1.07–1.26) 1.09 (0.99–1.19) 1.18 (1.03–1.35)
Liver (etc.) (C22) 0.92 (0.80–1.07) 0.91 (0.77–1.07) 0.83 (0.68–1.02) 0.59 (0.42–0.84)
Pancreatic (C25) 1.77 (1.61–1.94) 1.59 (1.44–1.75) 1.47 (1.31–1.64) 1.31 (1.11–1.54)
Laryngeal (C32) 0.75 (0.58–0.97) 0.82 (0.62–1.08) 0.80 (0.57–1.13) 0.93 (0.57–1.53)
Tracheal, bronchial and lung (C33–C34) 1.16 (1.09–1.23) 1.15 (1.07–1.23) 1.12 (1.03–1.21) 1.12 (1.00–1.25)
Melanoma skin cancer (C43) 1.46 (1.26–1.69) 1.31 (1.12–1.54) 1.52 (1.28–1.81) 1.53 (1.19–1.96)
Sarcoma (C46–C49) 1.90 (1.52–2.38) 1.74 (1.39–2.19) 1.54 (1.20–1.98) 1.58 (1.12–2.23)
Breast (C50) 0.96 (0.88–1.05) 0.99 (0.90–1.09) 0.94 (0.84–1.04) 0.93 (0.79–1.08)
Cervical (C53) 1.10 (0.87–1.39) 1.06 (0.83–1.36) 1.30 (1.00–1.69) 1.43 (1.01–2.03)
Uterine (C54–55) 1.35 (1.13–1.62) 1.36 (1.11–1.66) 1.16 (0.93–1.45) 1.15 (0.82–1.62)
Ovarian (etc.) (C56,C570–C574) 1.57 (1.38–1.78) 1.38 (1.20–1.58) 1.56 (1.35–1.80) 1.52 (1.23–1.86)
Prostate (C61) 1.32 (1.21–1.44) 1.54 (1.40–1.69) 1.04 (0.93–1.18) 1.58 (1.34–1.87)
Testicular (C62) 0.50 (0.26–0.99) 0.68 (0.34–1.37) 0.63 (0.25–1.56) 1.11 (0.40–3.06)
Kidney (etc.) (C64–C66) 1.46 (1.28–1.66) 1.49 (1.30–1.71) 1.19 (1.01–1.40) 1.28 (1.01–1.63)
Bladder (C67) 1.04 (0.92–1.17) 1.13 (0.99–1.29) 0.92 (0.78–1.08) 1.06 (0.83–1.35)
Brain/CNS (C70–C71, C751–C753)a 1.05 (0.98–1.17) 0.85 (0.75–0.97) 1.30 (1.13–1.49) 0.97 (0.78–1.20)
Thyroid (C73) 1.54 (1.07–2.22) 1.49 (1.01–2.20) 1.29 (0.83–2.00) 1.25 (0.64–2.43)
Unknown primary cancer (C76–C80) 0.93 (0.83–1.04) 0.89 (0.79–1.00) 0.99 (0.86–1.13) 0.86 (0.69–1.07)
Hodgkin disease (C81) 0.33 (0.17–0.63) 0.37 (0.18–0.77) 0.52 (0.23–1.17) 0.65 (0.21–2.03)
Non-Hodgkin lymphoma (C82–C85) 0.49 (0.42–0.60) 0.41 (0.33–0.51) 0.70 (0.56–0.87) 0.50 (0.33–0.74)
Multiple myeloma (C 90) 0.50 (0.42–0.61) 0.52 (0.42–0.65) 0.55 (0.42–0.72) 0.46 (0.28–0.73)
Leukemia (C91–C95) 0.34 (0.29–0.40) 0.29 (0.23–0.35) 0.47 (0.38–0.58) 0.18 (0.10–0.30)
Other cancer (all other C codes) 0.91 (0.83–1.00) 0.96 (0.87–1.07) 0.90 (0,80–1,02) 0.99 (0,83–1,19)
Average of all diagnoses 1 (ref) 1 (ref) 1 (ref) 1 (ref)
aIncluding the following D-codes: D32, D42, D330–332, D352–354, D430–432, D443–445, D333–339 and D433–439
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older patients may not receive the care they need,
maybe because symptoms and death are more accepted
in relation to older than younger patients. It is unknown
whether other parts of the health care system compensate
for the lower admission to SPC among the older patients,
e.g., whether the needs are adequately covered by primary
care, where they may already be in close contact with the
general practitioner, or via nursing homes.
Comparing the overall admittance to SPC of patients
with different cancer diagnoses, admittance was highest
for patients with sarcoma, pancreatic and stomach cancers
and lowest for patients with haematological malignancies.
According to the previous study of advanced cancer
patients the patterns for admittance cannot be explained
by differences in needs: the patient groups having higher
admittance did not have more symptoms and problems,
and patients with haematological malignancies did not
have fewer symptoms [5, 6]. However, there may of course
be differences in needs that were not revealed in the
questionnaires used. Previous studies have also found
that, patients with haematological malignancies were less
often admitted to SPC [26, 27]. It has also been reported
that the patients with haematological cancer are referred
closer to death than patients with other cancer diagnoses
and receive more aggressive treatment towards the end of
life [28–31]. The fact that active cancer treatment of this
patient group continues until close to death may explain
why these patients less often are admitted to SPC. It may
be a wish from the patients to continue their trajectory at
the haematological departments and not be referred to a
new and unknown SPC unit. More research is needed to
better understand the referral of patients with haemato-
logical malignancies to SPC. In relation to gynaecological
and gastrointestinal cancer we found like Hui et al. higher
odds of admittance to SPC [27], especially for ovarian, pan-
creatic and stomach cancers, but with marked variation
between the different cancer types in each subgroup and
between admittance to hospital-based palliative care team/
unit and hospice. Other studies found lower admittance
for breast cancer compared to colorectal cancer patients
[22] and lung cancer patients [32], similar to the present
study but different from the study by Hui et al. [27].
Differences in admittance in relation to type of institution
were primarily found in relation to patients with brain and
prostate cancer. Possibly, some types of cancer are more
compatible with certain types of care than others. The care
of patients with prostate cancer more frequently takes place
in hospital-based palliative teams/units, and this may reflect
that it can take place in the home of the patient. The care
of brain cancer patients may be more demanding, with dif-
ficult symptoms such as cognitive impairment and person-
ality changes, which may be more difficult to accommodate
by the family caregivers, leading to hospice referral.It is a recurring discussion in studies of admittance to
SPC whether differences between subgroups reflect a
real difference in need or an inequality, as the burden of
symptoms and problems (reflecting the need) are unknown.
It is a strength of this study that it has been possible to
compare admittance to SPC against the pattern of symp-
toms and problems in a nationally sample covering all ad-
vanced cancer patient. Of course, the comparison has some
limitations, for example the EORTC QLQ-C30 ques-
tionnaire, which was used may not cover all relevant
aspects, for example the availability of help and social
support at home.
Given the large differences in admittance in relation to
sex, age and diagnosis, future research should investigate
whether the groups having the lowest admittance have
uncovered needs of SPC (e.g. via surveys of patients not
admitted or by evaluating whether those admitted have
more needs, indicating a higher degree of selection). It
could also be relevant to compare end of life outcomes
reported by bereaved carers. Finally, it would be relevant
to compare the geographic patterns in more detail.
This study examines “overall admittance to SPC”. The
DPD includes the date and type of initial contact with
SPC but does not contain the detailed data about the
frequency and nature of additional contacts with SPC. In
an ongoing development project we are working on estab-
lishing such data from other registries but these data are
not yet available. When such detailed data about the
number and nature of SPC contacts become available,
they can answer important additional research questions.
In this study SPC was separated into the two categories,
hospital-based palliative care team/unit and hospice. This is
a construction with limitations, because about 20% of the
hospices have outgoing palliative teams and 20% of the
hospital-based palliative care teams/units have SPC units
with in-patients like hospices. On the other hand there are
some clear differences between hospices and hospitals e.g.
the organisation, financing and whether or not it takes
place within the hospital system, which makes the distinc-
tion meaningful. However, due to the fact that each of the
categories did include aspects from the ‘opposite’, our
categorisation may underestimate the differences between
hospital-based palliative care team/unit and hospice.
Conclusion
In this first nation-wide register-based study of admittance
to SPC among patients with cancer we found lower overall
admittance for men, older patients and patients with
haematological malignancies. Compared with hospital-
based palliative care team/unit, admittance to hospice was
lower for men and for patients with prostate cancer
whereas admittance to hospice was higher for patients
with brain cancers. The large variation in admittance to
SPC found in this study in relation to sex, age and cancer
Adsersen et al. BMC Palliative Care  (2017) 16:21 Page 8 of 9types cannot be explained by the variation in symp-
toms and problems among advanced cancer patients in
general. Future research should investigate whether
the groups having the lowest admittance to SPC re-
ceive sufficient palliative care.
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